Abstract
The concept of shock has evolved throughout the centuries, since the early descriptions of traumatic injury. Hippocrates (460–380 BC) recognized certain principles of wound care, such as elevating an injured limb; however, at that time the correlation between blood loss and death had not yet been identified. In the twentieth century, two physiologists, Cannon and Bayliss, developed studies in laboratory animals, postulating that systemic responses resulting from severe muscle injury were caused by a toxin that caused motor tonus loss, venous blood sequestration, and hypotension [1].
Keywords
- Growth Hormone
- Critical Illness
- Growth Hormone Administration
- Negative Nitrogen Balance
- Euthyroid Sick Syndrome
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Cannon WB, Bayliss WM. Notes on muscle injury in relation to shock: special report of the Medical Research Commission. 1919;26:19.
Blalock A. Experimental shock, the cause of the low blood pressure produced by muscle injury. Arch Surg. 1930;22:959.
Marchick MR, Kline JA, Jones AE. The significance of non-sustained hypotension in emergency department patients with sepsis. Intensive Care Med. 2009;35:1261–4.
Demling R, LaLonde C, Saldinger P, Knox J. Multiple-organ dysfunction in the surgical patient: pathophysiology, prevention, and treatment. Curr Probl Surg. 1993;30:345.
Hume DM, Egdahl RH. The importance of the brain in the endocrine response to injury. Ann Surg. 1959;150:697.
Kehlet H. Modification of responses to surgery and anesthesia by neural blockade. In: Cousins MJ, Bridenbaugh PO, editors. Neural blockade in clinical anesthesia and management of pain. Philadelphia: J.B. Lippincott; 1987. p. 145.
Jeschke MG, Mlcak RP, Herndon DN. Morphologic changes of the liver after a severe thermal injury. Shock. 2007;28(2):172–7.
Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med. 2008;34:17–60.
Lavery GG, Glover P. The methabolic and nutritional response to critical illness. Curr Opin Crit Care. 2000;6:233–8.
Arafah BM. Hypothalamic pituitary adrenal function during critical illness: limitations of current assessment methods. J Clin Endocrinol Metab. 2006;91:3725–45.
Marik P. Critical illness-related corticosteroid insufficiency. Chest. 2009;135:181–93.
Van den Berghe G, Wouters P, Bowers CY, et al. Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotropin and prolactin release in prolonged critical illness. Eur J Endocrinol. 1999;140:17–22.
Reichlin S. Neuroendocrine-immune inter-actions. N Engl J Med. 1993;329:1246–53.
Goodall MC, Stone C, Haynes Jr BW. Urinary output of adrenaline and noradrenaline in severe thermal burns. Ann Surg. 1957;145:479–87.
Wilmore DW, Aulick LH. Metabolic changes in burned patients. Surg Clin North Am. 1978;58:1173–87.
De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362:779–89.
Reiss W, Pearson E, Artz CP. The metabolic response to burns. J Clin Invest. 1956;35:62–77.
Newsome TW, Mason Jr AD, Pruitt Jr BA. Weight loss following thermal injury. Ann Surg. 1973;178:215–7.
Hart DW, Wolf SE, Mlcak RP, et al. Persistence of muscle catabolism after severe burn. Surgery. 2000;128:312–9.
Herndon D, Hart D, Wolf S, et al. Reversal of catabolism by beta-blockade after severe burns. N Engl J Med. 2001;345:1223–9.
Gore DC, Wolfe RR. Hemodynamic and metabolic effects of selective beta1 adrenergic blockade during sepsis. Surgery. 2006;139:686–94.
Baron PW, Barrow RE, Pierre EJ, et al. Prolonged use of propranolol safely decreases cardiac work in burned children. J Burn Care Rehabil. 1997;18:223–7.
Panina-Bordignon P, Mazzeo D, Lucia PD, et al. Beta2-agonists prevent Th1 development by selective inhibition of interleukin-12. J Clin Invest. 1997;100:1513–9.
Hasko G, Szabo C, Nemeth ZH, et al. Stimulation of beta-adrenoreceptors inhibits endotoxin-induced IL-12 production in normal and IL-10 deficient mice. J Neuroimmunol. 1998;88:57–61.
Sanders VM, Baker RA, Ramer-Quinn DS, et al. Differential expression of the beta2- adrenergic receptor by TH1 and Th2 clones: implications for cytokine production and B cell help. J Immunol. 1997;158:4200–10.
Borger P, Hoekstra Y, Esselink MT, et al. Beta-adrenoceptor-mediated inhibition of IFN-gamma, IL-3, and GM-CSF mRNA accumulation in activated human T lymphocytes is solely mediated by the beta2-adrenoceptor subtype. Am J Respir Cell Mol Biol. 1998;19:400–7.
Hasko G, Elenkov IJ, Kvetan V, et al. Differential effect of selective block of alpha 2-adrenoreceptors on plasma levels of tumor necrosisfactor – alpha, interleukin – 6 and corticosterone induced by bacterial lipopoly-saccharide in mice. J Endocrinol. 1995;144:457–62.
Kovacs KJ, Elenkov IJ. Differential dependence of ACTH secretion induced by various cytokines on the integrity of the paraventricular nucleus. J Neuroendocrinol. 1995;7:15–23.
Woiciechowsky CK, Asadullah K, Nestler D, et al. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat Med. 1998;4:808–13.
Fleshner M, Goehler LE, Schwartz BA, et al. Thermogenic and corticosterone responses to intravenous cytokines are attenuated by sub diaphragmatic vagotomy. J Neuroimmunol. 1998;86:134–41.
Maier SF, Goehler LE, Fleshner M, et al. The role of the vagus nerve in cytokine-to-brain communication. Ann N Y Acad Sci. 1998;840:289–300.
Watkins LR, Goehler LE, Relton JK, et al. Blockade of interleukin-1 induced hyperthermia by sub diaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication. Neurosci Lett. 1995;183:27–31.
Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000;405:458–62.
Guslandi M. Nicotine treatment for ulcerativecolitis. Br J Physiol Opt. 1998;274:L970–9.
Sandborn WJ. Transdermal nicotine for mildly to moderately active ulcerative colitis: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1997;126:364–71.
Sher ME. The influence of cigarette smoking on cytokine levels in patients with inflammatory bowel disease. Inflamm Bowel Dis. 1999;5:73–8.
McEwen B. Protective and damaging effects of stress mediators. N Engl J Med. 1998;338:171–9.
Seeman TE, Robbins RJ. Aging and hypothalamic-pituitary-adrenal response to challenge in humans. Endocr Rev. 1994;15:233–60.
Bessey PQ, Watters JM, Aoki TT, Wilmore DW. Combined hormonal infusion simulates the metabolic response to injury. Ann Surg. 1984;200:264.
Wilmore DW. The metabolic management of the critically ill. New York: Plenum Medical; 1977.
Annetta MG, Maviglia R, Proietti R, Antonelli M. Use of corticosteroids in critically ill septic patients: a review of mechanisms of adrenal insufficiency in sepsis and treatment. Curr Drug Targets. 2009;10:887–94.
Marik P, Pastores SM, Annane D, Meduri GU, Sprung CL, Arlt W, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med. 2008;36:1937–49.
Watt I, Ledingham IM. Mortality amongst multiple trauma patients admitted to an intensive therapy unit. Anaesthesia. 1984;39:973–81.
Annane D, Sébille V, Troché G. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA. 2000;283:1038–45. Short corticotropin test has prognostic value in predicting risk of death in sepsis.
Galigniana MD, Piwien-Pilipuk G, Assreuy J. Inhibition of glucocorticoid receptor binding by nitric oxide. Mol Pharm. 1999;55:317–23.
Wohltmann CD, Spain DA, Carrillo EH. Does gender effect outcome in trauma patients? Crit Care Med. 1999;27:A176.
Balteskard L, Unneberg K, Mjaaland M, et al. Treatment with growth hormone and insulin-like growth factor-1 in septicemia: effects on carbohydrate metabolism. Eur Surg Res. 1998;30:79–94.
Chopra IJ. Clinical review 86. Euthyroid sick syndrome: is it a misnomer? J Clin Endocrinol Metab. 1997;82:329–834.
Davies PH, Sheppard MC, Franklyn JA. Inflammatory cytokines and type I 5’-deiodinase expression in phi1 rat liver cells. Mol Cell Endocrinol. 1997;129:191–8.
Brent GA, Hershman JM. Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. J Clin Endocrinol Metab. 1986;63:1–8.
Aygen B, Inan M, Doganay M, Kelestimur F. Adrenal functions in patients with sepsis. Exp Clin Endocrinol Diabetes. 1997;105:182–6.
Bornstein SR, Licinio J, Tauchnitz R, et al. Plasma leptin levels are increased in survivors of acute sepsis: associated loss of diurnal rhythm in cortisol and leptin secretion. J Clin Endocrinol Metab. 1998;83:280–3.
Carlson GL, Saeed M, Little RA, Irving MH. Serum leptin concentrations and their relation to metabolic abnormalities in human sepsis. Am J Physiol. 1999;276:E658–62.
Van den Berghe G, Wouters P, Carlsson L, et al. Leptin levels in protracted critical illness; effects of growth hormone-secretagogues and thyrotropin-releassing hormone. J Clin Endocrinol Metab. 1998;83:3062–70.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Younes, R.N., Abrão, F.C. (2013). Neuroendocrine Response and Shock. In: Gabriel, E., Gabriel, S. (eds) Inflammatory Response in Cardiovascular Surgery. Springer, London. https://doi.org/10.1007/978-1-4471-4429-8_1
Download citation
DOI: https://doi.org/10.1007/978-1-4471-4429-8_1
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-4428-1
Online ISBN: 978-1-4471-4429-8
eBook Packages: MedicineMedicine (R0)